Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

News from GeekWire [GeekWire]( | [View in browser]( BREAKING NEWS Wednesday, Jun 9, 2021 Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development. Co-founded in 2016 by Institute for Systems Biology alum Parag Mallick (above, right) and Isilon Systems co-founder Sujal Patel (left), Nautilus is coming up with a way to analyze the proteome, the set of proteins in a biological sample. [READ THE STORY]( Follow [@geekwire]( for updates. Send [us a news tip](. Share [our newsletter.]( [Forward to Friend]( [Forward to Friend]( [Share]( [Share]( [Tweet]( [Tweet]( [Share]( [Share]( Copyright © 2021 GeekWire LLC, All rights reserved. You are receiving this email because you opted to receive emails from GeekWire. Our mailing address is: GeekWire LLC 123 NW 36th St Suite 203Seattle, Washington 98107 [Add us to your address book]( [unsubscribe from this list]( [update subscription preferences](